Open original FDA record ↗Recall record
- FDA identifier
- Z-2817-2018
- Company in FDA record
- bioMerieux, Inc.
- FDA classification date
- Aug 30, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Customer reports indicated an increase in the rate of non-detected MRSA in association with the VITEK 2 AST-P631 product.
Source facts
- Action
- bioMerieux sent an Urgent Product Correction Notice letter to their French customers on January 26, 2018. Customer letters in the Americas were sent August 21, 2018. The letters identified the affected product, problem, and actions to be taken. Customers should follow steps outlined in the letter and contact bioMerieux for any additional questions regarding these corrective actions. Note: the actions do not include removal of the product. For any questions or concerns, contact your local bioMerieux representative.
- Initiated
- 2018-01-26
- Root cause
- Under Investigation by firm
- Terminated
- 2019-05-20
- Distribution
- Worldwide distribution. US nationwide including Puerto Rico, Bermuda, Brazil, Canada, China, Curacao, Costa Rica, Dominican Republic, Ecuador, France, Guatemala, Indonesia, Israel, Hong Kong, South Korea, South Africa, Mexico, Myanmar, Nicaragua, Peru, Philippines, Paraguay, Singapore, Thailand, El Salvador, and Vietnam.
- Recall number
- Z-2817-2018
- Recall status
- Terminated
- CDRH record ID
- 165899
- FDA classified
- 2018-08-30
- Recall event number
- 80619